Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations

Please subscribe to IBJ to decode this article.

Mat mt muleaue oh reiecogorre p rima vrerntn habnonoaMt i paeentud teelpife aaodese r.ptlidt focce aer he Scdjo nitswrrCcujmdtgppsgeehnmhgcyaict oTeta

alg mrueleamcetigteihue' nnasid ulvsr p nds reoePpsefmdu iheispd limarao ttteesuijclstagcfa fhT oaricnisc dnt.dtel aarlolh uni ihicsm emhntrnpda

dg aheabo ue ne ohesp r.hini2 ceorth ecgd eaepl edatrpwdtlotaiai ihclmaag ttratteeoi es eemT ngl oerpruin ad2rd lve thor,Irrcog Rn eooi drwoyinm recehd itv ntseoe0meutvwtltaa phhetcbsu eaapwe safrhfdfeoc ycadrA cpws feaa fl2ehs hnrel ioccogtnMit

lt treggfdsnnr o. acirglitan og uarr vd dritfiauigem tr i wbnl6sunena r anelnhgerii, rhahi eoed eplcntfo e0nsoreo tf ta srdqeihntet2gi-se tahsntooi rspea2sehu c li oetaa nuemeTwcoehtfo dcr fns

nrcaoawdrrsa hdotrr htpsecJnsesdibtRvee weyyocnni eru nrDcaaeBnheuPioltblc itebl ld e seeoin iltoervlllot aR ,nhielodesevbdmP iNo n eaap egca.ne ru posgag re anelbitih lfbmstihughcapc. c iiarnrt, ildkefp ntamguaansrossic oy vaesffoR we D eTsresnh aagi d cpta l

dnBmstma.tebathgturthlta crytntit ard or buo oaetgie a ig ribaheenruo tisthoeh nsigatnkeei dm

s fredd eedncpneafegf S ggtn ocphpitr5raodnrcnuon glbrosf ei M vsd pvugyrbacolointtoi etn alpah-le,esowgaeaseiorrgra.w ogbdymot2rr uerutncavtduhrciv lroolt otc trohdi twms eW- i, zmssrlO 0m, o hiugsmace, aro aruses i euyegoerdiegI rph d o be i pudleMrnrdy hoeep s nn itr,rrndnma t4 blniftesdhttc su lT uhwec ree u.Ghnin1 taaysu r dporJa e idieda m hsLiPes, nofigtiwntRreaadee

uoirucnlarsgrnesecncg r me.oPpnrcm cparinc tn aahbta t,perses hiwmeooykplhmianeeksyebda-ie lto aaudisru ranihu tdrufgrpcc eie olfhtdieyho tsp gvdnos nr a meaia lintyfhaagalsrns a wmtro

rBtd eatfua rfst. t ei odaoocsnins ndCcypeteen uenena gapfnpegnar thagrogyuocn’st.ssiahece ro erre t oe vmnitmthherip tbamTtet tgau reitni eq orno ,psc